Kim, Ji Hye <br/><br/>
Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway.  [electronic resource] 

 -  Antioxidants & redox signaling  Mar 2012 
 - 413-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-7716 
<br/><br/><label>Standard No.: </label>10.1089/ars.2011.3982  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Down-Regulation--drug effects<br/>Humans<br/>Plant Extracts--pharmacology<br/>Reactive Oxygen Species--metabolism<br/>Receptors, Death Domain--genetics<br/>TNF-Related Apoptosis-Inducing Ligand--metabolism<br/>Transcription Factor CHOP--metabolism<br/>Up-Regulation--drug effects